The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127861661 12786166 1 I 20160921 20160927 20160927 EXP US-SUNOVION-2016SUN002350 SUNOVION ITTASAKUL P, ARCHER A, KEZMAN J, ATSARIYASING W, GOLDMAN M. RAPID RECHALLENGE WITH CLOZAPINE FOLLOWING PRONOUNCED MYOCARDITIS IN A TREATMENT-RESISTANT SCHIZOPHRENIA PATIENT. CLINICAL SCHIZOPHRENIA AND RELATED PSYCHOSES. 2016;SUMMER 2016:120-122 20.00 YR M Y 0.00000 20160927 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127861661 12786166 1 PS LATUDA LURASIDONE HYDROCHLORIDE 1 Oral 80 MG, QD Y 200603 80 MG TABLET QD
127861661 12786166 2 SS LATUDA LURASIDONE HYDROCHLORIDE 1 Oral 240 MG, QD Y 200603 240 MG TABLET QD
127861661 12786166 3 SS CLOZAPINE. CLOZAPINE 1 UNK D 0
127861661 12786166 4 SS CLOZAPINE. CLOZAPINE 1 450 MG, UNK D 0 450 MG
127861661 12786166 5 SS CLOZAPINE. CLOZAPINE 1 25 MG, UNK D 0 25 MG
127861661 12786166 6 SS CLOZAPINE. CLOZAPINE 1 50 MG, UNK D 0 50 MG
127861661 12786166 7 SS CLOZAPINE. CLOZAPINE 1 75 MG, UNK D 0 75 MG
127861661 12786166 8 SS CLOZAPINE. CLOZAPINE 1 100 MG, QD D 0 100 MG QD
127861661 12786166 9 SS CLOZAPINE. CLOZAPINE 1 125 MG, QD D 0 125 MG QD
127861661 12786166 10 SS CLOZAPINE. CLOZAPINE 1 200 MG, QD D 0 200 MG QD
127861661 12786166 11 SS CLOZAPINE. CLOZAPINE 1 750 MG, UNK D 0 750 MG
127861661 12786166 12 SS CLOZAPINE. CLOZAPINE 1 UNK D 0
127861661 12786166 13 SS OLANZAPINE. OLANZAPINE 1 40 MG, QD D 0 40 MG QD
127861661 12786166 14 SS OLANZAPINE. OLANZAPINE 1 UNK D 0
127861661 12786166 15 C RISPERIDONE. RISPERIDONE 1 3 MG, QD 0 3 MG QD
127861661 12786166 16 C ZIPRASIDONE. ZIPRASIDONE 1 80 MG, QD 0 80 MG QD
127861661 12786166 17 C PERPHENAZINE. PERPHENAZINE 1 24 MG, QD 0 24 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127861661 12786166 1 Schizophrenia

Outcome of event

Event ID CASEID OUTC COD
127861661 12786166 OT
127861661 12786166 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127861661 12786166 Aggression
127861661 12786166 C-reactive protein increased
127861661 12786166 Chest pain
127861661 12786166 Ejection fraction decreased
127861661 12786166 Electrocardiogram T wave abnormal
127861661 12786166 Eosinophil count increased
127861661 12786166 Hallucination, auditory
127861661 12786166 Headache
127861661 12786166 Leukocytosis
127861661 12786166 Mental impairment
127861661 12786166 Myocarditis
127861661 12786166 Nasal congestion
127861661 12786166 Oropharyngeal pain
127861661 12786166 Paranoia
127861661 12786166 Pyrexia
127861661 12786166 Tachycardia
127861661 12786166 Troponin I increased
127861661 12786166 Ventricular hypokinesia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found